Clinical Research of Spastic Paralysis after Stroke by Acupuncture

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TCH-11001547

Enrollment

Unknown

Registered

2011-08-26

Start date

2011-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic Paralysis after Stroke

Interventions

Control group:Basic treatment and Rehabilitation treatment

Experimental group:Based therapy, rehabilitation, acupuncture, traditional Chinese medicine, and massage therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Comply with the above diagnostic criteria of cerebral infarction and increased muscle tone; 2. First onset and duration 1-3 months; 3. A ged 40-80 years old, diagnosis of cerebral infarction or lacunar infarction by cranial CT or MRI, and consciously; 4. Line with the treatment and examination; 5. Patients who have signed informed consent of entered the study.

Exclusion criteria

Exclusion criteria: 1. Transient ischemic attack (TIA); 2. Stroke with disturbance of consciousness and unstable conditions; 3. Abnormal intracranial vascular disease complicated with brain tumors, brain trauma, brain parasites and so on; 4. Complicated with liver (ALT, AST more than normal upper limit 50%), kidney (BUN above normal upper limit 20%, Cr beyond the upper limit of normal range), hematopoietic system, metabolic system and other serious diseases; mentally and dementia patients; 5. Suspected or indeed alcohol, drug abuse history; or according to the researchers to determine, reducing enter group possibility, or some other lesions or conditions make enter complicated, which easily lead to lost the case such as frequent changes in the work environment, unstable living environment; 6. Bleeding tendency; 7. Pregnancy or breast-feeding women; 8. Used within four weeks the major organs are known to damage the drugs; 9. The patient can not cooperate, is participating in other clinical trials or other clinical trials drugs within a month.

Design outcomes

Primary

Measure	Time frame
Scandinavian Stroke Scale;NIHSS Stroke Scale;Simplify Fugl-Meyer Scale;	—

Secondary

Measure	Time frame
Revised Barthel index;Mortality and relapse rate after follow-up period;Modified Ashworth Scale;	—

Countries

China

Contacts

Public ContactShi Xuemin

tjdrshi@msn.com+86 022 27432008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026